Arsenite activates NFκB through induction of C-reactive protein

Ingrid L. Druwe, James J. Sollome, Pablo Sanchez-Soria, Rhiannon N. Hardwick, Todd D Camenisch, Richard Vaillancourt

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

C-reactive protein (CRP) is an acute phase protein in humans. Elevated levels of CRP are produced in response to inflammatory cytokines and are associated with atherosclerosis, hypertension, cardiovascular disease and insulin resistance. Exposure to inorganic arsenic, a common environmental toxicant, also produces cardiovascular disorders, namely atherosclerosis and is associated with insulin-resistance. Inorganic arsenic has been shown to contribute to cardiac toxicities through production of reactive oxygen species (ROS) that result in the activation of NFκB. In this study we show that exposure of the hepatic cell line, HepG2, to environmentally relevant levels of arsenite (0.13 to 2 μM) results in elevated CRP expression and secretion. ROS analysis of the samples showed that a minimal amount of ROS are produced by HepG2 cells in response to these concentrations of arsenic. In addition, treatment of FvB mice with 100. ppb sodium arsenite in the drinking water for 6. months starting at weaning age resulted in dramatically higher levels of CRP in both the liver and inner medullary region of the kidney. Further, mouse Inner Medullary Collecting Duct cells (mIMCD-4), a mouse kidney cell line, were stimulated with 10. ng/ml CRP which resulted in activation of NFκB. Pretreatment with 10 nM Y27632, a known Rho-kinase inhibitor, prior to CRP exposure attenuated NFκB activation. These data suggest that arsenic causes the expression and secretion of CRP and that CRP activates NFκB through activation of the Rho-kinase pathway, thereby providing a novel pathway by which arsenic can contribute to metabolic syndrome and cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)263-270
Number of pages8
JournalToxicology and Applied Pharmacology
Volume261
Issue number3
DOIs
StatePublished - Jun 15 2012

Fingerprint

C-Reactive Protein
Arsenic
Chemical activation
Reactive Oxygen Species
rho-Associated Kinases
Insulin Resistance
Atherosclerosis
Cardiovascular Diseases
Insulin
Kidney
Cell Line
Disease Resistance
arsenite
Acute-Phase Proteins
Metabolic Diseases
Hep G2 Cells
Protein C
Weaning
Drinking Water
Liver

Keywords

  • Arsenite
  • CRP
  • Metabolic syndrome

ASJC Scopus subject areas

  • Pharmacology
  • Toxicology

Cite this

Arsenite activates NFκB through induction of C-reactive protein. / Druwe, Ingrid L.; Sollome, James J.; Sanchez-Soria, Pablo; Hardwick, Rhiannon N.; Camenisch, Todd D; Vaillancourt, Richard.

In: Toxicology and Applied Pharmacology, Vol. 261, No. 3, 15.06.2012, p. 263-270.

Research output: Contribution to journalArticle

Druwe, Ingrid L. ; Sollome, James J. ; Sanchez-Soria, Pablo ; Hardwick, Rhiannon N. ; Camenisch, Todd D ; Vaillancourt, Richard. / Arsenite activates NFκB through induction of C-reactive protein. In: Toxicology and Applied Pharmacology. 2012 ; Vol. 261, No. 3. pp. 263-270.
@article{92d170bce8d243fa939a64a41eee69ac,
title = "Arsenite activates NFκB through induction of C-reactive protein",
abstract = "C-reactive protein (CRP) is an acute phase protein in humans. Elevated levels of CRP are produced in response to inflammatory cytokines and are associated with atherosclerosis, hypertension, cardiovascular disease and insulin resistance. Exposure to inorganic arsenic, a common environmental toxicant, also produces cardiovascular disorders, namely atherosclerosis and is associated with insulin-resistance. Inorganic arsenic has been shown to contribute to cardiac toxicities through production of reactive oxygen species (ROS) that result in the activation of NFκB. In this study we show that exposure of the hepatic cell line, HepG2, to environmentally relevant levels of arsenite (0.13 to 2 μM) results in elevated CRP expression and secretion. ROS analysis of the samples showed that a minimal amount of ROS are produced by HepG2 cells in response to these concentrations of arsenic. In addition, treatment of FvB mice with 100. ppb sodium arsenite in the drinking water for 6. months starting at weaning age resulted in dramatically higher levels of CRP in both the liver and inner medullary region of the kidney. Further, mouse Inner Medullary Collecting Duct cells (mIMCD-4), a mouse kidney cell line, were stimulated with 10. ng/ml CRP which resulted in activation of NFκB. Pretreatment with 10 nM Y27632, a known Rho-kinase inhibitor, prior to CRP exposure attenuated NFκB activation. These data suggest that arsenic causes the expression and secretion of CRP and that CRP activates NFκB through activation of the Rho-kinase pathway, thereby providing a novel pathway by which arsenic can contribute to metabolic syndrome and cardiovascular disease.",
keywords = "Arsenite, CRP, Metabolic syndrome",
author = "Druwe, {Ingrid L.} and Sollome, {James J.} and Pablo Sanchez-Soria and Hardwick, {Rhiannon N.} and Camenisch, {Todd D} and Richard Vaillancourt",
year = "2012",
month = "6",
day = "15",
doi = "10.1016/j.taap.2012.04.005",
language = "English (US)",
volume = "261",
pages = "263--270",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Arsenite activates NFκB through induction of C-reactive protein

AU - Druwe, Ingrid L.

AU - Sollome, James J.

AU - Sanchez-Soria, Pablo

AU - Hardwick, Rhiannon N.

AU - Camenisch, Todd D

AU - Vaillancourt, Richard

PY - 2012/6/15

Y1 - 2012/6/15

N2 - C-reactive protein (CRP) is an acute phase protein in humans. Elevated levels of CRP are produced in response to inflammatory cytokines and are associated with atherosclerosis, hypertension, cardiovascular disease and insulin resistance. Exposure to inorganic arsenic, a common environmental toxicant, also produces cardiovascular disorders, namely atherosclerosis and is associated with insulin-resistance. Inorganic arsenic has been shown to contribute to cardiac toxicities through production of reactive oxygen species (ROS) that result in the activation of NFκB. In this study we show that exposure of the hepatic cell line, HepG2, to environmentally relevant levels of arsenite (0.13 to 2 μM) results in elevated CRP expression and secretion. ROS analysis of the samples showed that a minimal amount of ROS are produced by HepG2 cells in response to these concentrations of arsenic. In addition, treatment of FvB mice with 100. ppb sodium arsenite in the drinking water for 6. months starting at weaning age resulted in dramatically higher levels of CRP in both the liver and inner medullary region of the kidney. Further, mouse Inner Medullary Collecting Duct cells (mIMCD-4), a mouse kidney cell line, were stimulated with 10. ng/ml CRP which resulted in activation of NFκB. Pretreatment with 10 nM Y27632, a known Rho-kinase inhibitor, prior to CRP exposure attenuated NFκB activation. These data suggest that arsenic causes the expression and secretion of CRP and that CRP activates NFκB through activation of the Rho-kinase pathway, thereby providing a novel pathway by which arsenic can contribute to metabolic syndrome and cardiovascular disease.

AB - C-reactive protein (CRP) is an acute phase protein in humans. Elevated levels of CRP are produced in response to inflammatory cytokines and are associated with atherosclerosis, hypertension, cardiovascular disease and insulin resistance. Exposure to inorganic arsenic, a common environmental toxicant, also produces cardiovascular disorders, namely atherosclerosis and is associated with insulin-resistance. Inorganic arsenic has been shown to contribute to cardiac toxicities through production of reactive oxygen species (ROS) that result in the activation of NFκB. In this study we show that exposure of the hepatic cell line, HepG2, to environmentally relevant levels of arsenite (0.13 to 2 μM) results in elevated CRP expression and secretion. ROS analysis of the samples showed that a minimal amount of ROS are produced by HepG2 cells in response to these concentrations of arsenic. In addition, treatment of FvB mice with 100. ppb sodium arsenite in the drinking water for 6. months starting at weaning age resulted in dramatically higher levels of CRP in both the liver and inner medullary region of the kidney. Further, mouse Inner Medullary Collecting Duct cells (mIMCD-4), a mouse kidney cell line, were stimulated with 10. ng/ml CRP which resulted in activation of NFκB. Pretreatment with 10 nM Y27632, a known Rho-kinase inhibitor, prior to CRP exposure attenuated NFκB activation. These data suggest that arsenic causes the expression and secretion of CRP and that CRP activates NFκB through activation of the Rho-kinase pathway, thereby providing a novel pathway by which arsenic can contribute to metabolic syndrome and cardiovascular disease.

KW - Arsenite

KW - CRP

KW - Metabolic syndrome

UR - http://www.scopus.com/inward/record.url?scp=84861235577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861235577&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2012.04.005

DO - 10.1016/j.taap.2012.04.005

M3 - Article

C2 - 22521605

AN - SCOPUS:84861235577

VL - 261

SP - 263

EP - 270

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 3

ER -